{"name":"Global Blood Therapeutics","slug":"global-blood-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOZTVhLVpoMmRrZGpjMGdJelJoS1BBcXVQVkFPdHQ2N0Z4OHJBWDZLTmlQX1ZJS2U4N1JpMFBIQzdRcmpLTmVhQXY2RlBxbjFlcU1wMVdWWm1PT3otY3BVUlBBOFZaZGZxNEJtRHRKRUd1ekluZ0t4VmlQR0ZWU2F0Njd2NklQajdTM1htUjlSVmctRVpuTjNZeWtpLWlkVXY3SGlMMzNyUWhtWWFnVTVwM2YtNm9Bb1FrOTJkdzlUbks?oc=5","date":"2026-04-08","type":"pipeline","source":"Fierce Pharma","summary":"Pfizer walks away from 'underutilized' office space in South San Francisco, transitions employees to remote roles - Fierce Pharma","headline":"Pfizer walks away from 'underutilized' office space in South San Francisco, transitions employees to remote roles","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNTTNTV2IySHpqYk5abDJMb0pSU1czMVMySDJWdG1VVHRpbU9JNDJjenphOHFSeHF5Qm5zYW1jTEFhVHhoU3VJQmd4UWk3SnFMaUZuUFFXTlNMLUdiMkRqUVVPWS15ZnQtM0s0MEhEWXllU2lULVFWbWgzY1ZuZkNkVW5aVnVVaFV1dlp2TXp1R0JXanZUUEdNOHd0djV6S1JXbEpGcm9OMTRBMzRoR3h1VGhGVi1UZGZBcDgw?oc=5","date":"2025-08-18","type":"trial","source":"Fierce Biotech","summary":"Pfizer's SCD drug fails phase 3 study in latest blow to Global Blood Therapeutics' legacy - Fierce Biotech","headline":"Pfizer's SCD drug fails phase 3 study in latest blow to Global Blood Therapeutics' legacy","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPbFhDa0RVaVhiRV95Z3lGYW53aTJlbEtyRWpkbHZaRlNqNUlfaW1uVlVXaVAxNGNfWEJ0eGxLSGRrSGk5M1cxSkFlMkFTb05FSmFlTDNSdWU2d2p4eW9MMGI3WFI3b20ycmEyMVNRbjI1TVV3NDhjeFY0QnBtQkVtZDNnclRVSWN6Qk5hYTUwTzdzVW9tdGpqRWd4OXBfSkd2amhwZGZMeTk0OENHdlJ1OGEyVi1mSkxlWVVUdElNNA?oc=5","date":"2025-08-18","type":"trial","source":"BioSpace","summary":"Pfizer’s $5.4B GBT Bet Disappoints Again as Sickle Cell Therapy Fails in Phase III - BioSpace","headline":"Pfizer’s $5.4B GBT Bet Disappoints Again as Sickle Cell Therapy Fails in Phase III","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9oQV9WZ2xQYTRubEJWV1J1UTdnRDJvd1k0cjM5Y0VnRFRWdmNhUkxOSFVJSkJ4YWhHNmg2OGw3UGFnNGR4R1pXQW1PaFBUWjlHMjRZ?oc=5","date":"2025-08-15","type":"pipeline","source":"FirstWord Pharma","summary":"Pfizer's sickle cell woes continue with late-stage failure of inclacumab - FirstWord Pharma","headline":"Pfizer's sickle cell woes continue with late-stage failure of inclacumab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNS1hGZy1fRVZpZGU3MUVMdFJpRWpOTGFjaTlpY3owcmJFSlVlaGZHVWF2QnhoWUNyNDdtdXRwLXpDeUJjUWZLdTVhdVFobThQOEdmWHNrYUxwNjV3OXZnVURwNjE1d0hCRC1JcUlidFEtNzg0ekJGai1yd2gxSUZwLUMwb2QxNWc?oc=5","date":"2022-10-06","type":"deal","source":"Pharmaceutical Technology","summary":"Pfizer acquires Global Blood Therapeutics for $5.4bn - Pharmaceutical Technology","headline":"Pfizer acquires Global Blood Therapeutics for $5.4bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOLVhjeWtpTHVkV1pHVnljcmtvTDc1V2ptMGlSMm1Ccmw0STBTVUR1U1ZESTJYZ3hpLVlvZDM4dUdfSXZZSm9rREtBNURGNHkxQ1JaenUwMllGLTBmSklKcVZRRjZGUjlpc0l0NWFSSEpaQXhDT0gtRFctRE1QN3A4YVBMTGVMWWp0VlBIQWRYYVFSV3Y2S1ZDd0hJS2RlUkJCQlFyZk9NaERlcVJKUTRGcTdrZWZpZw?oc=5","date":"2022-08-09","type":"deal","source":"European Pharmaceutical Review","summary":"Pfizer to acquire Global Blood Therapeutics in $5.4bn deal - European Pharmaceutical Review","headline":"Pfizer to acquire Global Blood Therapeutics in $5.4bn deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQQUM5UXd0TWhla0hzeE9CUE9rcVVYTzVxcWNjdXROTGV4TVFWMEtoUjB0bHZqNGxpd1RIUE1XZmF1TS14TlBhT2gzUndRcUhBRVdQMmp3Sm1PR0NlWnppenBvU3dyTGllcDFMbE8zekNpRFZBOHM0OVN5cXkzX2trQ2diWExLTnd5NFNsRXVObHRwWXR3cVFtZW40QmNTNmhfYzNkMDNUS1pRdU4tZEFPUkRMTDhNbm9xRnhBbw?oc=5","date":"2022-08-08","type":"deal","source":"reuters.com","summary":"Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 billion deal - reuters.com","headline":"Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 billion deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOZ0JZekNKUTZfMWNJTUxhcW9nc0ItNHQwbGpBYlA2d0xmS2JMRDRXYThyLXlzdmhHNy1vVXQ4Z1oyOFVvYS12eWtNSGZIME5rVmNBNlhSTHNQRGhtNDhqV291Z0hybEkzOTh3NzRXdk5SVjBqQ1lhU1NYRHBCME1KZjdBQll0UkhvVElIZUZid3lLMUdXeVAtVldxb19Mcko4LXfSAacBQVVfeXFMT0JvTDhTOURGYkZVYWJ3R2dsT3R4dWZLZUVFTXNZOURWaXd3MWhWNDg1Tko5T3BYOGtjQ3JOWmE5MUQ4Yngxb1hkczlNZVJjWFA1aG9JU3ptb29vYmF6aFhKRGNsdDN3Z19qd2syRWpkZ1c1cVRDZFoyMFFnb1g4bTZFeHNwR2hIbEZubVR5b3dCc2lKSUUyVUo1SGtDUW5NZ21tal9QU3c?oc=5","date":"2022-08-08","type":"deal","source":"CNBC","summary":"Pfizer to buy Global Blood Therapeutics in $5.4 billion deal - CNBC","headline":"Pfizer to buy Global Blood Therapeutics in $5.4 billion deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNX2hTTkdocmR6OGVVaGdVeTNkYzlHR1NzdHdKaUl6Q0NRakRXQnRIZ2k2eVNhX3JmaF93OUxSMmtQUk8tWWM1RnRicnp0TXJjbTVTbF93bGhLQkY0ZXItcVo4SklzS1JpVUR0QnFVTjA4Tmpsb3phUXNLVXNpbExyT09oX3FTVXhYVmVrNkRMVWRJeWFJaGhzNW5B?oc=5","date":"2022-08-08","type":"deal","source":"BioPharma Dive","summary":"Pfizer buys sickle cell drugmaker Global Blood for $5.4B - BioPharma Dive","headline":"Pfizer buys sickle cell drugmaker Global Blood for $5.4B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQMmpwLW9MZjA0QXdVd2huenJXVXgwVUVQNUxDOTkzN19zc043NVo5VXJub3pQX3ZZdzVUeTEzVHRvbnpfS3FiLWV5WHJEZGstMG5WRkx6Z0pjc3VBbFdLUlM0LXZ0WkdORnRZLWFCU0otcG1EaWJaRnZMVksyRmhTaGFkN2VQUkxUMDk2SnZaVFVLMXBlZUhLUlFSUUFhR3VUd2xyZnlnUlJIT294Yk9xajRXYmc0YU40VWdLNnZ4cm0?oc=5","date":"2022-08-05","type":"deal","source":"WSJ","summary":"Exclusive | Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion - WSJ","headline":"Exclusive | Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOSDhFMlRJSFNGVUVDSzYwbDlsc1FMY1VrX0VCQUY5N0FaUC0ycWRoUDkxQnBvYVZVVnE1V293OEwwdklSTE5ORVpIRzZyc25MdkM0T2FJaDZQSnkwTHNxN0dTYXJyNU5ZSXBIUnk1dENhT2xEWDJMX1VQSEN1ZFpMNExvZVZJeFUxcXd2a3o5bVhfZUtrcHBqb0NOeTBiVFRGMEMwSGExUklCVVNTTVFj?oc=5","date":"2022-08-04","type":"pipeline","source":"Bloomberg.com","summary":"Sickle Cell Drug Maker Global Blood Therapeutics Draws Takeover Interest - Bloomberg.com","headline":"Sickle Cell Drug Maker Global Blood Therapeutics Draws Takeover Interest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOVGg3M2FPclNaT19WdmcwRmdZcXhuNlZDVkpkSkx1aERaZFBERXNRM1dYSG1seDlyUTBtNV9ibTB2Uk1DSFFjVFFqTmxNb3BLR0hZMGs1Q2Z4N0FGcUFTQUN5NkdLSHJpeVBzaG5XZzdLbWs1UnV3aTBFSFJUczQzeTJsdDVPcGRKdklB?oc=5","date":"2022-04-19","type":"pipeline","source":"Pharma Voice","summary":"For Global Blood Therapeutics, the connection to sickle cell disease runs deep - Pharma Voice","headline":"For Global Blood Therapeutics, the connection to sickle cell disease runs deep","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}